🔎 Trials Near Me

Início › Câncer de Mama › Nova York › New York City

Ensaios clínicos de Câncer de Mama em New York City, NY

136 estudos para Câncer de Mama estão buscando participantes em locais em New York City e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.

Texto oficial do estudo (Inglês)

Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

RecrutandoFase 1/2
  • Research Site, New York
  • Research Site, New York
Idades de 18 a 130 · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT05417594

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

RecrutandoFase 3
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University Irving Medical Center, New York
  • e mais 1
Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT06982521

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

Recrutando
  • Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT04751435

A Study of Mental Health Care in People With Cancer

Recrutando
  • Memorial Sloan Kettering Cancer Center, New York
Idades 65 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT06037954

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

RecrutandoFase 1
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT06784193

A Study of PHST001 in Advanced Solid Tumors

RecrutandoFase 1
  • Mount Sinai, New York
Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT06840886

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

RecrutandoFase 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05534438

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

RecrutandoFase 1/2
  • Columbia University Medical Center, New York
  • Memorial Sloan Kettering, New York
Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

RecrutandoFase 3
  • Mount Sinai School of Medicine, New York
Idades de 18 a 100 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

RecrutandoFase 3
  • Research Site, New York
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07205822

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

RecrutandoFase 2
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07102381

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

RecrutandoFase 2
  • Memorial Sloan Kettering Hospital, New York
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06172478

A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

RecrutandoFase 1/2
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07701941

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

RecrutandoFase 1
  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06625775

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

RecrutandoFase 1/2
  • Memorial Sloan-Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06324357

A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer

Recrutando
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07218250

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

RecrutandoFase 2
  • New York Proton Center, New York
Idades 50 e acima · Mulheres · Atualizado em 29 de set. de 2026 · NCT01766297

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

RecrutandoFase 1
  • Research Site, New York
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT05877599

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy

RecrutandoFase 3
  • New York Proton Center, New York
Idades 19 e acima · Mulheres · Atualizado em 29 de set. de 2026 · NCT05856773

Study of AVZO-021 in Patients With Advanced Solid Tumors

RecrutandoFase 1/2
  • Avenzo Therapeutics Recruiting Site, New York
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05867251

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

RecrutandoFase 3
  • Laura and Isaac Perlmutter Cancer Center-Hematology and Oncology ( Site 0068), New York
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06312176

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

RecrutandoFase 2
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07007559

A Study of Language Interpretation Solutions for People With Breast Cancer

Recrutando
  • Memorial Sloan Kettering at Ralph Lauren Center (All Protocol Activities), New York
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06721065

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

RecrutandoFase 1
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Mulheres · Atualizado em 24 de set. de 2026 · NCT05412225

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Recrutando
  • NYU Langone Health, New York
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07214532

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

RecrutandoFase 3
  • Clinical Trial Site, New York
  • Clinical Trial Site, New York
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07085767

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

RecrutandoFase 1
  • New York University (NYU) Langone Medical Center, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

RecrutandoFase 1
  • New York University (NYU) Clinical Cancer Center, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07213791

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

RecrutandoFase 3
  • Memorial Sloan Kettering Cancer Center, New York
  • NYC Health + Hospitals / Bellevue, New York
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07174336

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

RecrutandoFase 2
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Mulheres · Atualizado em 22 de set. de 2026 · NCT07287098

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

RecrutandoVoluntários saudáveis bem-vindos
  • Weill Cornell Medicine, New York
Idades de 30 a 74 · Mulheres · Atualizado em 21 de set. de 2026 · NCT02620852

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

RecrutandoFase 2
  • Memorial Sloan Kettering Cancer Center, New York
Idades 45 e acima · Mulheres · Atualizado em 21 de set. de 2026 · NCT04084730

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

RecrutandoFase 1/2
  • Beth Israel Comprehensive Cancer Center, New York
  • Mount Sinai Medical Center, New York
  • Icahn School of Medicine at Mount Sinai PRIME, New York
  • e mais 2
Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT06827236

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

RecrutandoFase 3
  • Paradigm New York Cancer and Blood Specialists, New York
  • Paradigm New York Cancer and Blood Specialists, New York
  • Paradigm New York Cancer and Blood Specialists, New York
  • e mais 5
Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07173751

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
  • Memorial Sloan Kettering Cancer Center (All protocol activites), New York
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT06780176

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

RecrutandoFase 3
  • The Blavatnik Family - Chelsea Medical Center at Mount Sinai, New York
  • Laura and Isaac Perlmutter Cancer Center/NYU Langone Health, New York
  • Mount Sinai West, New York
  • e mais 2
Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT06492616

A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer

RecrutandoFase 1
  • Memorial Sloan Kettering Cancer Center (All protocol activites), New York
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT06246968

A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery

RecrutandoFase 1/2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Idades 18 e acima · Mulheres · Atualizado em 11 de set. de 2026 · NCT05130801

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

RecrutandoFase 1
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
Idades 18 e acima · Todos os sexos · Atualizado em 10 de set. de 2026 · NCT06293898

A Phase 1/1b Study of IAM1363 in HER2 Cancers

RecrutandoFase 1
  • Icahn School of Medicine at Mount Sinai, New York
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT06253871

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

RecrutandoFase 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT05570253

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

RecrutandoFase 1
  • Chelsea Medical Center at Mount Sinai, New York
Idades de 18 a 55 · Mulheres · Atualizado em 9 de set. de 2026 · NCT07310420

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

RecrutandoFase 1/2
  • NYU Langone Health Perlmutter Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT05315700

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

RecrutandoFase 1
  • New York University (NYU) Clinical Cancer Center, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT06400472

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

RecrutandoFase 3
  • The Blavatnik Family ? Chelsea Medical Center at Mount Sinai, New York
  • Mount Sinai West, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • e mais 1
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06790693

Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors

RecrutandoEstudo observacional
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Mulheres · Atualizado em 3 de set. de 2026 · NCT05590949

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

RecrutandoFase 3
  • Manhattan Hematology /Oncology Associates, New York
  • New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C (NY), New York
Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06072612

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

RecrutandoFase 3
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Manhattan Eye Ear and Throat Hospital, New York
  • e mais 2
Idades de 18 a 60 · Mulheres · Atualizado em 2 de set. de 2026 · NCT05879926

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Recrutando
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT05837767

Study of Aerobic Training for People Receiving Treatment for Breast Cancer

RecrutandoFase 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Idades 18 e acima · Mulheres · Atualizado em 27 de ago. de 2026 · NCT05716893

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

RecrutandoFase 1
  • New York Cancer & Blood Specialists, New York
Idades 18 e acima · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT06582017

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

RecrutandoFase 1/2
  • Memorial Sloan Kettering, New York
Idades de 18 a 100 · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT06726148

A Study of Romosozumab in People With Breast Cancer and Osteoporosis

RecrutandoFase 2
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Mulheres · Atualizado em 20 de ago. de 2026 · NCT07776613

HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission

RecrutandoFase 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT07459673

ATEMPT 2.0: Adjuvant T-DM1 vs TH

RecrutandoFase 2
  • New York University Langone Health, New York
  • Northwell University, New York
Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT04893109

Decision Support Tool for Patients With Advanced Breast Cancer

Recrutando
  • NewYork-Presbyterian David H. Koch Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT07635147

Optimizing Surgical Decisions in Young Adults With Breast Cancer

Recrutando
  • Weill Cornell Medicine, New York
Idades de 18 a 44 · Mulheres · Atualizado em 19 de ago. de 2026 · NCT06275126

A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer

RecrutandoFase 2
  • Memorial Sloan-Kettering Cancer Center (All Protocol Activities), New York
Idades 70 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT07768436

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

RecrutandoFase 3
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • New York Proton Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT06500481

Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer

RecrutandoFase 2
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
Idades 18 e acima · Todos os sexos · Atualizado em 14 de ago. de 2026 · NCT06518057

Medical Imaging and Focused Ultrasound Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI)

RecrutandoFase 1
  • Columbia University Irving Medical Center/NYP, New York
Idades 18 e acima · Mulheres · Atualizado em 13 de ago. de 2026 · NCT05219695

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

RecrutandoFase 3
  • New York-Presbyterian - Columbia University Irving Medical Center, New York
Idades de 18 a 100 · Todos os sexos · Atualizado em 6 de ago. de 2026 · NCT05232916

E-Mindfulness Approaches for Living After Breast Cancer

RecrutandoFase 3
  • Mount Sinai Union Square, New York
  • Mount Sinai Chelsea, New York
  • Mount Sinai West, New York
  • e mais 1
Idades de 18 a 50 · Todos os sexos · Atualizado em 4 de ago. de 2026 · NCT06748222

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

Recrutando
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT07225309

MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

Recrutando
  • Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Idades 18 e acima · Todos os sexos · Atualizado em 31 de jul. de 2026 · NCT06954337

Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts

RecrutandoVoluntários saudáveis bem-vindos
  • Memorial Sloan Kettering Cancer Center, New York
Idades de 45 a 74 · Mulheres · Atualizado em 31 de jul. de 2026 · NCT05625659

A Study of a Side Effects and Resource Navigation Program for People With Cancer

Recrutando
  • City College of New York (Data Collection AND Specimen Analysis), New York
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Idades 18 e acima · Todos os sexos · Atualizado em 31 de jul. de 2026 · NCT07646847

Adherence Intervention in Patients With Metastatic Breast Cancer

Recrutando
  • Columbia University Medical Center, New York
Idades de 18 a 99 · Todos os sexos · Atualizado em 28 de jul. de 2026 · NCT06121453

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

RecrutandoFase 2
  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
Idades 8 e acima · Todos os sexos · Atualizado em 27 de jul. de 2026 · NCT05503797

Radiation After No Axillary Nodal Sampling

Recrutando
  • NYU Langone Health, New York
Idades 40 e acima · Mulheres · Atualizado em 23 de jul. de 2026 · NCT07723209

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

RecrutandoFase 1
  • Investigative Site #103, New York
  • Investigative Site #106, New York
Idades 18 e acima · Todos os sexos · Atualizado em 23 de jul. de 2026 · NCT06545942

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

RecrutandoFase 1
  • Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
  • Memorial Sloan Kettering Cancer Center 53rd street., New York
  • Memorial Sloan Kettering Cancer Center - Main Campus, New York
Idades 18 e acima · Todos os sexos · Atualizado em 22 de jul. de 2026 · NCT07318805

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

RecrutandoFase 4
  • Weill Cornell Medicine, New York
Idades 18 e acima · Mulheres · Atualizado em 22 de jul. de 2026 · NCT07257484

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Recrutando
  • NYU Langone Health, New York
  • Columbia University Medical Center, New York
Idades de 18 a 99 · Mulheres · Atualizado em 17 de jul. de 2026 · NCT05592938

A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement

RecrutandoFase 4
  • Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Idades 18 e acima · Mulheres · Atualizado em 10 de jul. de 2026 · NCT07220967

Opioid Dispensing Device for Post-Operative Pain in Cancer Patients

Recrutando
  • Columbia University Medical Center, New York
Idades de 18 a 99 · Todos os sexos · Atualizado em 10 de jul. de 2026 · NCT05585788

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

RecrutandoFase 2
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 10 de jul. de 2026 · NCT06695845

A Study of a Decision Tool for People Considering Breast Reconstruction Surgery

Recrutando
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 9 de jul. de 2026 · NCT07335354

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

RecrutandoFase 1/2
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 7 de jul. de 2026 · NCT05768139

A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Idades 18 e acima · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT05438511

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

RecrutandoFase 1/2
  • New York University Langone Health, New York
  • ICHAN School of Medicine at Mount Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT05377996

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

RecrutandoFase 3
  • The Blavatnik Family - Chelsea Medical Center at Mount Sinai, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 22 de jun. de 2026 · NCT05696626

Two Versus One Week Breast Radiotherapy (RT)

RecrutandoFase 3
  • Brooklyn Methodist Hospital, New York
  • New York Presbyterian Hospital, New York
  • New York-Presbyterian Weill Cornell Medical College, New York
Todas as idades · Mulheres · Atualizado em 15 de jun. de 2026 · NCT06960707

Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job

Recrutando
  • Bellevue Hospital Center (Data Collection Only), New York
  • Memorial Sloan Kettering Cancer Center, New York
Idades de 18 a 64 · Mulheres · Atualizado em 12 de jun. de 2026 · NCT03572374

A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer

RecrutandoFase 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Idades 50 e acima · Mulheres · Atualizado em 4 de jun. de 2026 · NCT07483307

Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

Recrutando
  • VA New York Harbor Health Care System - Manhattan, New York
  • VA New York Harbor Healthcare System - Harlem Community Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 3 de jun. de 2026 · NCT06559059

Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients

RecrutandoEstudo observacional
  • Memorial Sloan-Kettering Cancer Center, New York
Idades 18 e acima · Mulheres · Atualizado em 3 de jun. de 2026 · NCT02772367

A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

Recrutando
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Idades 18 e acima · Mulheres · Atualizado em 2 de jun. de 2026 · NCT06127979

A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

RecrutandoFase 1
  • Memorial Sloan Kettering Cancer Center (All protocol activites), New York
Idades 18 e acima · Todos os sexos · Atualizado em 28 de mai. de 2026 · NCT06678269

Elacestrant in Advanced Triple Positive Breast Cancer

RecrutandoFase 1/2
  • NYU Langone Health, New York
Idades 18 e acima · Mulheres · Atualizado em 28 de mai. de 2026 · NCT07612215

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

RecrutandoFase 3
  • Weill Cornell Medical College - NewYork-Presbyterian Hospital, New York
Idades 18 e acima · Todos os sexos · Atualizado em 18 de mai. de 2026 · NCT06757634

A Study of Blood Pressure Control During Cancer Treatment

RecrutandoFase 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Idades 18 e acima · Mulheres · Atualizado em 14 de mai. de 2026 · NCT06023576

Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer

RecrutandoFase 1 inicial
  • Mount Sinai Health System, New York
Idades 18 e acima · Todos os sexos · Atualizado em 14 de mai. de 2026 · NCT06637306

A Study of Surgery and Radiotherapy in People With Breast Cancer

RecrutandoFase 2
  • Memorial Sloan Kettering Cancer Center (All protocol activites), New York
Idades 18 e acima · Todos os sexos · Atualizado em 14 de mai. de 2026 · NCT07053085

Brodalumab in the Treatment of Immune-Related Adverse Events

RecrutandoFase 1
  • Columbia University Irving Medical Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 13 de mai. de 2026 · NCT06673329

Lymphedema Surveillance Study

RecrutandoEstudo observacional
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Mulheres · Atualizado em 7 de mai. de 2026 · NCT02743858

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

RecrutandoFase 2
  • Laura and Isaac Perlmutter Cancer Center / NYU Langone Health, New York
  • Columbia University Medical Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 6 de mai. de 2026 · NCT01042379

IMPACT Trial: Intervention to iMProve AdherenCe Equitably

Recrutando
  • Columbia University Medical Center, New York
Idades de 18 a 99 · Todos os sexos · Atualizado em 6 de mai. de 2026 · NCT05496829

Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial

RecrutandoFase 2
  • Weill Cornell Medicine, New York
Idades 18 e acima · Mulheres · Atualizado em 6 de mai. de 2026 · NCT03990896

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

RecrutandoFase 3
  • Mount Sinai Union Square, New York
  • Mount Sinai Chelsea, New York
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • e mais 5
Idades de 50 a 70 · Todos os sexos · Atualizado em 23 de abr. de 2026 · NCT04852887

Factors Associated With Breast Cancer Risks and Outcomes

RecrutandoEstudo observacional
  • Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Idades 18 e acima · Mulheres · Atualizado em 17 de abr. de 2026 · NCT07294703

Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors

Recrutando
  • The New York Proton Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 13 de abr. de 2026 · NCT05313191

Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer

RecrutandoFase 1/2Voluntários saudáveis bem-vindos
  • Mount Sinai Beth Israel, New York
  • Mount Sinai - West, New York
  • Dubin breast Center, New York
Idades de 18 a 90 · Todos os sexos · Atualizado em 13 de abr. de 2026 · NCT05095207

Breast Cancer Implementation Science Study With Educational Intervention

Recrutando
  • NYU Langone Health, New York
Idades 18 e acima · Todos os sexos · Atualizado em 30 de mar. de 2026 · NCT06927895

Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

RecrutandoFase 1/2
  • Weill Cornell Medicine, New York
  • Brooklyn Methodist Hospital - NewYork Presbyterian, New York
  • New York Presbyterian Hospital - Queens, New York
Idades de 19 a 90 · Mulheres · Atualizado em 30 de mar. de 2026 · NCT03449238

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

RecrutandoFase 1/2
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 27 de mar. de 2026 · NCT06395519

Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
  • Weill Cornell Medicine of Cornell University, New York
Idades de 30 a 75 · Mulheres · Atualizado em 11 de mar. de 2026 · NCT07219277

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

RecrutandoEstudo observacional
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Mulheres · Atualizado em 4 de mar. de 2026 · NCT01788839

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

RecrutandoFase 2
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 27 de fev. de 2026 · NCT03808337

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

RecrutandoFase 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Idades 18 e acima · Todos os sexos · Atualizado em 25 de fev. de 2026 · NCT06099769

A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer

RecrutandoFase 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Idades 18 e acima · Mulheres · Atualizado em 17 de fev. de 2026 · NCT04683679

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

RecrutandoFase 1
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 13 de fev. de 2026 · NCT06778863

AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc

Recrutando
  • Columbia University Irving Medical Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 12 de fev. de 2026 · NCT05351424

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

RecrutandoFase 1
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Idades 18 e acima · Todos os sexos · Atualizado em 11 de fev. de 2026 · NCT06623396

A Study of Revaree Plus in People With Breast Cancer

RecrutandoFase 4
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Mulheres · Atualizado em 6 de fev. de 2026 · NCT07042581

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

RecrutandoFase 1
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 29 de jan. de 2026 · NCT04150042

Converting HR+ Breast Cancer Into an Individualized Vaccine

RecrutandoFase 2
  • New York Presbyterian Hospital - Queens, New York
  • Weill Cornell Medicine New York Presbyterian Hospital, New York
  • Brooklyn Methodist Hospital - NewYork Presbyterian, New York
Idades de 18 a 90 · Mulheres · Atualizado em 28 de jan. de 2026 · NCT03804944

Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study

Recrutando
  • New York Presbyterian Hospital - Queens, New York
  • Weill Cornell Medicine, New York
Idades de 19 a 90 · Mulheres · Atualizado em 27 de jan. de 2026 · NCT04371913

Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol

RecrutandoFase 4
  • Memorial Sloan Kettering Cancer Center, New York
Idades de 18 a 65 · Todos os sexos · Atualizado em 30 de dez. de 2025 · NCT07308717

De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You

RecrutandoEstudo observacional
  • Brooklyn Methodist Hospital - NewYork Presbyterian, New York
  • New York Presbyterian Hospital - Queens, New York
Idades de 18 a 90 · Mulheres · Atualizado em 18 de dez. de 2025 · NCT05134779

Combined Immunotherapies in Metastatic ER+ Breast Cancer

RecrutandoFase 2
  • Weill Cornell Medicine, New York
  • Brooklyn Methodist Hospital - NewYork Presbyterian, New York
  • New York Presbyterian Hospital - Queens, New York
Idades de 18 a 90 · Mulheres · Atualizado em 15 de dez. de 2025 · NCT04563507

Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer

RecrutandoFase 4
  • New York-Presbyterian/Weill Cornell Medical Center, New York
Idades 18 e acima · Mulheres · Atualizado em 24 de nov. de 2025 · NCT06072807

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

RecrutandoFase 3
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Idades de 18 a 75 · Mulheres · Atualizado em 10 de nov. de 2025 · NCT06144164

Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer

Recrutando
  • Mount Sinai Hospital, New York
Idades 18 e acima · Mulheres · Atualizado em 5 de nov. de 2025 · NCT06405828

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecrutandoEstudo observacional
  • Massive Bio SYNERGY-AI site, New York
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774

Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)

RecrutandoEstudo observacional
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Idades 18 e acima · Mulheres · Atualizado em 14 de out. de 2025 · NCT05561842

Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
  • Memorial Sloan Kettering Cancer Center, New York
Idades de 18 a 44 · Mulheres · Atualizado em 14 de out. de 2025 · NCT00823654

The Cancer of the Pancreas Screening-5 CAPS5)Study

RecrutandoFase 3
  • NYU Langone Medical Center, New York
  • Columbia University Medical Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 9 de out. de 2025 · NCT02000089

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

RecrutandoFase 1
  • NYU Langone, New York
  • Columbia University Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering, New York
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2025 · NCT05216432

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

RecrutandoFase 1
  • Exelixis Clinical Site #5, New York
Idades 18 e acima · Todos os sexos · Atualizado em 5 de set. de 2025 · NCT05932862

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

RecrutandoEstudo observacional
  • Kings County Hospital, New York
Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2025 · NCT03053193

Breast Elasticity Imaging During Neoadjuvant Chemotherapy

Recrutando
  • Columbia University Irving Medical Center/NYP, New York
Idades 18 e acima · Mulheres · Atualizado em 29 de mai. de 2025 · NCT04824027

Comprehensive Outcomes for After Cancer Health

RecrutandoVoluntários saudáveis bem-vindos
  • Memorial Sloan Kettering Cancer Center, New York
Idades 18 e acima · Todos os sexos · Atualizado em 11 de dez. de 2024 · NCT05349227

Ensaios de Câncer de Mama em outras cidades

Outros estudos em New York City

Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.